Topic: Vitamin E Acetate

4 chapters across the catalog

Booby-Trap
Episode 1222 58:59 - 1:00:39

1222: Booby-Trap

Vape Industry Scandals and Vitamin E Acetate

Following his appearance on the Joe Rogan Experience, one of the hosts has been embraced by the vaping community for explaining the link between faulty THC cartridges containing vitamin E acetate and recent lung illnesses. The discussion touches on the acquisition of Juul and the market entry of IQOS, comparing the industry's struggles to the documentary "Who Killed the Electric Car?"

CIS-Cast
Episode 1189 2:28:10 - 2:31:27

1189: CIS-Cast

CDC Identifies Vitamin E Acetate in Vaping Illness

The CDC has identified vitamin E acetate as a "common suspect" in lung injuries linked to vaping after testing 29 samples of lung fluid. The substance is often used as a thickener in black market THC cartridges. The hosts argue that the mainstream media and politicians unfairly targeted the legal nicotine vaping industry (like Juul) to protect tobacco tax revenues.

Vapegoat
Episode 1172 1:46 - 8:56

1172: Vapegoat

Vape Wars, Industry Regulation, THC Health Risks

The "Vape Wars" involve a push by major industry players like Juul to secure market dominance through FDA regulations that disadvantage smaller competitors. Health concerns regarding lung illnesses are attributed to illicit THC cartridges containing vitamin E acetate rather than standard nicotine e-liquids. The FDA is moving toward banning flavored e-cigarettes, leaving only tobacco-flavored products on the market.

Slutty Vegan
Episode 1171 17:25 - 21:18

1171: Slutty Vegan

Vitamin E Acetate, THC Vaping Illness Investigation

The CDC and FDA are investigating a surge in respiratory illnesses linked to vaping, with a specific focus on vitamin E acetate found in black-market THC cartridges. While mainstream media reports often conflate nicotine vaping with illicit THC products, health officials suggest the thickening agents used in unregulated oils are the likely cause of lung damage. The regulatory response is expected to favor large, established companies capable of navigating expensive FDA approval processes.